Characterising Private and Shared Signatures of Positive Selection in 37 Asian Populations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Blueprint Genetics ABCC11 Single Gene Test
ABCC11 single gene test Test code: S02680 Phenotype information Apocrine gland secretion, variation in Alternative gene names MRP8 Test Strengths The strengths of this test include: CAP accredited laboratory CLIA-certified personnel performing clinical testing in a CLIA-certified laboratory Powerful sequencing technologies, advanced target enrichment methods and precision bioinformatics pipelines ensure superior analytical performance Careful construction of clinically effective and scientifically justified gene panels Our Nucleus online portal providing transparent and easy access to quality and performance data at the patient level Our publicly available analytic validation demonstrating complete details of test performance ~2,000 non-coding disease causing variants in our clinical grade NGS assay for panels (please see ‘Non-coding disease causing variants covered by this test’) Our rigorous variant classification scheme Our systematic clinical interpretation workflow using proprietary software enabling accurate and traceable processing of NGS data Our comprehensive clinical statements Test Limitations This test does not detect the following: Complex inversions Gene conversions Balanced translocations Mitochondrial DNA variants Repeat expansion disorders unless specifically mentioned Non-coding variants deeper than ±20 base pairs from exon-intron boundary unless otherwise indicated (please see above non-coding variants covered by the test). This test may not reliably detect the following: Low level mosaicism (variant with a minor allele fraction of 14.6% is detected with 90% probability) Stretches of mononucleotide repeats Indels larger than 50bp Single exon deletions or duplications Variants within pseudogene regions/duplicated segments The sensitivity of this test may be reduced if DNA is extracted by a laboratory other than Blueprint Genetics. For additional information, please refer to the Test performance section and see our Analytic Validation. -
Association Between the ABCC11 Gene Polymorphism and the Expression of Apolipoprotein D by the Apocrine Glands in Axillary Osmidrosis
MOLECULAR MEDICINE REPORTS 11: 4463-4467, 2015 Association between the ABCC11 gene polymorphism and the expression of apolipoprotein D by the apocrine glands in axillary osmidrosis ZHECHEN ZHU1, HONGWEI ZHANG1, GUANGHUA LUO2, NING XU3 and ZHONGLAN PAN1 1Department of Plastic and Burn Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210003; 2Comprehensive Laboratory, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China; 3Section of Clinical Chemistry and Pharmacology, Institute of Laboratory Medicine, Lund University, Lund S-221 85, Sweden Received April 1, 2014; Accepted December 9, 2014 DOI: 10.3892/mmr.2015.3274 Abstract. It has been suggested that the adenosine triphos- gene in the mediation of osmidrosis by enhancing the transi- phate-binding cassette sub-family C member 11 (ABCC11) tion of odor precursors via the ApoD pathway. gene polymorphism and apolipoprotein D (ApoD), an odor precursor carrier, may be important in the formation of axil- Introduction lary odor. To date, few studies have examined the potential correlation between these two factors. The present study Osmidrosis is one of the most common complaints in the aimed to investigate the association between a 538 G>A departments of plastic surgery at the First Affiliated Hospital single-nucleotide polymorphism (SNP) of the ABCC11 gene of Nanjing Medical University (Nanjing, China). The apocrine and the mRNA expression levels of ApoD in the apocrine glands, which are located in the axilla, are the predominant gland of patients with osmidrosis. The 538 G>A polymor- cause of axillary odor (1). This is due to the fat-like secretion phism genotypes of 33 patients with a clinical diagnosis of produced by the apocrine glands, which is broken down into osmidrosis were analyzed by polymerase chain reaction (PCR) volatile odorous substances by bacteria (2). -
Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice. -
P-Glycoprotein Drug Transporters in the Parasitic Nematodes Toxocara Canis and Parascaris
Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2019 P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris Jeba Rose Jennifer Jesudoss Chelladurai Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Parasitology Commons, and the Veterinary Medicine Commons Recommended Citation Jesudoss Chelladurai, Jeba Rose Jennifer, "P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris" (2019). Graduate Theses and Dissertations. 17707. https://lib.dr.iastate.edu/etd/17707 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris by Jeba Rose Jennifer Jesudoss Chelladurai A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Veterinary Pathology (Veterinary Parasitology) Program of Study Committee: Matthew T. Brewer, Major Professor Douglas E. Jones Richard J. Martin Jodi D. Smith Tomislav Jelesijevic The student author, whose presentation of the scholarship herein was approved by the program of study committee, is solely responsible for the content of this dissertation. The Graduate College will ensure this dissertation is globally accessible and will not permit alterations after a degree is conferred. Iowa State University Ames, Iowa 2019 Copyright © Jeba Rose Jennifer Jesudoss Chelladurai, 2019. -
A Functional ABCC11 Allele Is Essential in the Biochemical
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector See related commentary on pg 344 ORIGINAL ARTICLE A Functional ABCC11 Allele Is Essential in the Biochemical Formation of Human Axillary Odor Annette Martin1,3, Matthias Saathoff1,3, Fabian Kuhn2, Heiner Max1, Lara Terstegen1 and Andreas Natsch2 The characteristic human axillary odor is formed by bacterial action on odor precursors that originate from apocrine sweat glands. Caucasians and Africans possess a strong axillary odor ,whereas many Asians have only a faint acidic odor. In this study, we provide evidence that the gene ABCC11 (MRP8), which encodes an apical efflux pump, is crucial for the formation of the characteristic axillary odor and that a single-nucleotide polymorphism (SNP) 538G-A, which is prominent among Asian people, leads to a nearly complete loss of the typical odor components in axillary sweat. The secretion of amino-acid conjugates of human-specific odorants is abolished in homozygotic carriers of the SNP, and steroidal odorants and their putative precursors are significantly reduced. Moreover, we show that ABCC11 is expressed and localized in apocrine sweat glands. These data point to a key function of ABCC11 in the secretion of odorants and their precursors from apocrine sweat glands. SNP 538G-A, which also determines human earwax type, is present on an extended haplotype, which has reached 495% frequency in certain populations in recent human evolution. A strong positive selection in mate choice for low-odorant partners with a dysfunctional ABCC11 gene seems a plausible explanation for this striking frequency of a loss-of-function allele. -
ABCB1 and ABCC11 Confer Resistance to Eribulin in Breast Cancer Cell Lines
www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 43 Research Paper ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines Takaaki Oba1, Hiroto Izumi2, Ken-ichi Ito1 1Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, Japan 2Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan Correspondence to: Ken-ichi Ito, email: [email protected] Keywords: eribulin, drug resistance, breast cancer, ABCB1, ABCC11 Received: May 13, 2016 Accepted: August 09, 2016 Published: August 31, 2016 ABSTRACT This study aimed to elucidate the mechanisms underlying the resistance of breast cancer to eribulin. Seven eribulin-resistant breast cancer cell lines (MCF7/E, BT474/E, ZR75-1/E, SKBR3/E, MDA-MB-231/E, Hs578T/E, and MDA-MB-157/E) were established. mRNA and protein expression of ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 11 (ABCC11) increased in all eribulin-resistant cell lines compared to the parental cell lines. When ABCB1 or ABCC11 expression was inhibited by small interfering RNA in MCF7/E, BT474/E, and MDA-MB-231/E cells, eribulin sensitivity was partially restored. Moreover, eribulin resistance was attenuated additively by inhibiting ABCB1 and ABCC11 in MCF7/E cells. Additionally, overexpression of exogenous ABCB1 or ABCC11 in HEK293T cells conferred resistance to eribulin. MCF7/E and MDA- MB-231/E cells showed cross-resistance to paclitaxel, doxorubicin, and fluorouracil. Inhibition of ABCB1 partially restored paclitaxel and doxorubicin sensitivity. Partial restoration of fluorouracil sensitivity was induced by inhibiting ABCC11 in MCF7/E and MDA-MB-231/E cells. -
Gene Networks Activated by Specific Patterns of Action Potentials in Dorsal Root Ganglia Neurons Received: 10 August 2016 Philip R
www.nature.com/scientificreports OPEN Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons Received: 10 August 2016 Philip R. Lee1,*, Jonathan E. Cohen1,*, Dumitru A. Iacobas2,3, Sanda Iacobas2 & Accepted: 23 January 2017 R. Douglas Fields1 Published: 03 March 2017 Gene regulatory networks underlie the long-term changes in cell specification, growth of synaptic connections, and adaptation that occur throughout neonatal and postnatal life. Here we show that the transcriptional response in neurons is exquisitely sensitive to the temporal nature of action potential firing patterns. Neurons were electrically stimulated with the same number of action potentials, but with different inter-burst intervals. We found that these subtle alterations in the timing of action potential firing differentially regulates hundreds of genes, across many functional categories, through the activation or repression of distinct transcriptional networks. Our results demonstrate that the transcriptional response in neurons to environmental stimuli, coded in the pattern of action potential firing, can be very sensitive to the temporal nature of action potential delivery rather than the intensity of stimulation or the total number of action potentials delivered. These data identify temporal kinetics of action potential firing as critical components regulating intracellular signalling pathways and gene expression in neurons to extracellular cues during early development and throughout life. Adaptation in the nervous system in response to external stimuli requires synthesis of new gene products in order to elicit long lasting changes in processes such as development, response to injury, learning, and memory1. Information in the environment is coded in the pattern of action-potential firing, therefore gene transcription must be regulated by the pattern of neuronal firing. -
Insulin Resistance Intrudes AKT2's Protective Effects Against Neural
Issue 1, 2014 | 2014 High School GIDAS Research Conference | Poster abstracts Issue 1, 2014 | 2014 High School GIDAS Research Conference | Poster abstracts Insulin Resistance Intrudes AKT2’s Protective Effects Against Neural Keywords: ATK, FOXO1, phosphorylation, insulin resistance, apoptosis, Alzheimer’s disease Apoptosis References: 1. http://www.alz.org/alzheimers_disease_facts_and_figures.asp Cassidy Durkee 2. http://www.genecards.org/cgi-bin/carddisp.pl?gene=SH3RF1 3. http://www.sciencedirect.com/science/article/pii/S0092867407007751 12th grade, Community high school, Ann Arbor, MI, USA 4. http://www.ncbi.nlm.nih.gov/pubmed/9620559 5. http://www.ncbi.nlm.nih.gov/pubmed/21303257 Introduction 6. http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS4136 Alzheimer’s disease is the sixth leading cause of death in the United States, accountable for an 7. http://www-06.all-portland.net/bst/032/0350/0320350.pdf estimated 500,000 deaths in 2010 [1]. While it seems to affect individuals quite arbitrarily, there has been some question in the past about the role of diet in its development. In this abstract, we will look at the role of insulin resistance in neural apoptosis as noted in Alzheimer’s disease. The primary gene of focus will be AKT2, a kinase responsible for phosphorylating several important proteins, but most relevantly FOXO1 as it contributes to neural apoptosis [2]. Identifying kinase- substrate interactions and phosphorylation can yield uncertain results, but this relationship was previously confirmed using PDK1-PHKI embryonic stem cells [3]. AKT2 is activated by insulin I am a recent graduate from Community high [4], and it has been found that AKT2 plays a crucial role in preventing oxidative-stress-induced school in Ann Arbor, MI, and will be attending the apoptosis [5]. -
ABCC11 Gene Polymorphism As a Potential Predictive Biomarker for an Oral 5‑Fuorouracil Derivative Drug S‑1 Treatment in Non‑Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology (2019) 84:1229–1239 https://doi.org/10.1007/s00280-019-03959-3 ORIGINAL ARTICLE ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5‑fuorouracil derivative drug S‑1 treatment in non‑small cell lung cancer Takehiro Uemura1,2 · Tetsuya Oguri3 · Ken Maeno1 · Kazuki Sone1 · Akira Takeuchi1 · Satoshi Fukuda1 · Eiji Kunii4 · Osamu Takakuwa1 · Yoshihiro Kanemitsu1 · Hirotsugu Ohkubo1 · Masaya Takemura1 · Yutaka Ito1 · Akio Niimi1 Received: 11 March 2019 / Accepted: 5 September 2019 / Published online: 17 September 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Purpose ABCC11/MRP8 (ABCC11) is an ATP-binding cassette transporter that is involved in regulating cellular sensitiv- ity and resistance for many anti-cancer drugs. Since 5-fuorouracil (5-FU) is one of the substrates for ABCC11, we exam- ined whether ABCC11 is a predictive marker for an oral 5-FU derivative drug S-1 treatment in non-small cell lung cancer (NSCLC). Methods Real-time PCR and MTS assay were carried on 21 human NSCLC cell lines. The drug resistance capabilities of ABCC11 are evaluated by analyzing the resistance profles of a clone of HeLa cell in which the pump was ectopically expressed. Blood samples of 106 NSCLC patients were collected. Results There was a signifcant correlation between dihydropyrimidine dehydrogenase (DPD) gene expression and the IC 50 for 5-FU. We then classifed NSCLC cell lines into two groups based on the phenotype of the SNP538 (G > A) in ABCC11: a combined G/G and G/A group, and an A/A group. The distribution of the IC 50 for 5-FU in combination with a potent inhibitor of DPD 5-chloro-2, 4-dihydropyrimidine (CDHP), which is contained in S-1, showed a signifcant reduction in the A/A group compared with the combined G/G and G/A group. -
Atp-Binding Cassette Subfamily C (Abcc) Transporter 1 (Abcc1) and 4 (Abcc4) Independent of Their Drug Efflux Ability Affects Breast Cancer Biology
Some pages of this thesis may have been removed for copyright restrictions. If you have discovered material in Aston Research Explorer which is unlawful e.g. breaches copyright, (either yours or that of a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, libel, then please read our Takedown policy and contact the service immediately ([email protected]) ATP-BINDING CASSETTE SUBFAMILY C (ABCC) TRANSPORTER 1 (ABCC1) AND 4 (ABCC4) INDEPENDENT OF THEIR DRUG EFFLUX ABILITY AFFECTS BREAST CANCER BIOLOGY FLOREN GUY LOW Doctor of Philosophy ASTON UNIVERSITY December 2018 © Floren Guy Low, 2018 Floren Guy Low asserts his moral right to be identified as the author of this thesis. This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright belongs to its author and that no quotation from the thesis and no information derived from it may be published without appropriate permission or acknowledgement. 1 Aston University ATP-binding cassette subfamily C (ABCC) transporter 1 (ABCC1) and 4 (ABCC4) independent of their drug efflux ability affects breast cancer biology Floren Guy Low Doctor of Philosophy 2018 Thesis Summary Breast cancer treatment has been a challenge to date, due in part to cancer cells acquiring drug resistance. One of the mechanisms by which resistance can occur is the overexpression of drug efflux pumps such as ATP-binding cassette, subfamily C (ABCC) transporter 1 (ABCC1) and 4 (ABCC4), which are members of ABC transporters. Recently research has shown that these proteins may be implicated in cancer biology independent of cytotoxic drug efflux, but so far little is known about this in regards to breast cancer. -
Pleiotropic Roles of ABC Transporters in Breast Cancer
International Journal of Molecular Sciences Review Pleiotropic Roles of ABC Transporters in Breast Cancer Ji He 1 , Erika Fortunati 1, Dong-Xu Liu 2 and Yan Li 1,2,3,* 1 School of Science, Auckland University of Technology, Auckland 1010, New Zealand; [email protected] (J.H.); [email protected] (E.F.) 2 The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland 1010, New Zealand; [email protected] 3 School of Public Health and Interprofessional Studies, Auckland University of Technology, Auckland 0627, New Zealand * Correspondence: [email protected]; Tel.: +64-9921-9999 (ext. 7109) Abstract: Chemotherapeutics are the mainstay treatment for metastatic breast cancers. However, the chemotherapeutic failure caused by multidrug resistance (MDR) remains a pivotal obstacle to effective chemotherapies of breast cancer. Although in vitro evidence suggests that the overexpression of ATP-Binding Cassette (ABC) transporters confers resistance to cytotoxic and molecularly targeted chemotherapies by reducing the intracellular accumulation of active moieties, the clinical trials that target ABCB1 to reverse drug resistance have been disappointing. Nevertheless, studies indicate that ABC transporters may contribute to breast cancer development and metastasis independent of their efflux function. A broader and more clarified understanding of the functions and roles of ABC transporters in breast cancer biology will potentially contribute to stratifying patients for precision regimens and promote the development of novel therapies. Herein, we summarise the current knowledge relating to the mechanisms, functions and regulations of ABC transporters, with a focus on the roles of ABC transporters in breast cancer chemoresistance, progression and metastasis.